Statements (59)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:pharmaceuticals
|
gptkbp:age_group |
12 years and older
|
gptkbp:approves |
gptkb:2002
|
gptkbp:available_on |
gptkb:pharmaceuticals
|
gptkbp:brand |
gptkb:Mucinex_DM
gptkb:Mucinex_Sinus-Max Mucinex Fast-Max Mucinex Children's |
gptkbp:clinical_trial |
studied for efficacy in cough relief
studied for safety in children |
gptkbp:contraindication |
allergy to guaifenesin
|
gptkbp:dosage_form |
extended-release tablet
liquid syrup |
gptkbp:form |
gptkb:tablet
gptkb:liquid |
https://www.w3.org/2000/01/rdf-schema#label |
Mucinex
|
gptkbp:ingredients |
guaifenesin
sodium coloring agents artificial flavor propylene glycol sorbitol |
gptkbp:interacts_with |
may interact with other medications
may interact with alcohol |
gptkbp:is_effective_against |
effective for cough suppression
effective for mucus clearance may cause increased mucus production not a cough suppressant |
gptkbp:manufacturer |
gptkb:Reckitt_Benckiser
|
gptkbp:packaging |
gptkb:bottle
blister pack |
gptkbp:regulatory_compliance |
FDA approved
available in multiple countries |
gptkbp:route_of_administration |
oral
|
gptkbp:side_effect |
dizziness
headache nausea allergic reaction rash drowsiness dry mouth gastrointestinal upset |
gptkbp:storage |
store at room temperature
|
gptkbp:strength |
600 mg
1200 mg 200 mg/5 m L |
gptkbp:target_audience |
adults
children over 12 |
gptkbp:used_for |
relief of cough
thinning mucus |
gptkbp:wildlife |
do not exceed recommended dose
consult doctor if breastfeeding consult doctor if pregnant consult doctor if taking other medications |
gptkbp:bfsParent |
gptkb:Pfizer_Consumer_Healthcare
gptkb:Super_Bowl_XXXII gptkb:Reckitt_Benckiser gptkb:Vicks |
gptkbp:bfsLayer |
5
|